✦ LIBER ✦

A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia

✍ Scribed by Adrian Tempescul; Johanna Feuerbach; Jean-Christophe Ianotto; Florence Dalbies; Veronique Marion; Marie-Josée Le Bris; Marc De Braekeleer; Christian Berthou

Book ID: 105989189
Publisher: Springer
Year: 2008
Tongue: English
Weight: 124 KB
Volume: 88
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-008-0541-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitoxantrone in combination with an inhi

Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia

✍ Sarah L. Elliott; Clark Crawford; Evan Mulligan; Geoffrey Summerfield; Paula New 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

Combination therapy with rituximab and i

Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type

✍ Antonio Salar; Eva Domingo-Domenech; Cristina Estany; Miguel A. Canales; Fernand 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 3 views